GE HealthCare CFO buys 3,310 GEHC shares

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro purchased 3,310 shares of Common Stock in an open-market transaction on May 1, 2026 at a weighted average price of $60.5997 per share.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Chief Financial Officer James Saccaro purchased 3,310 shares of Common Stock in an open-market transaction on May 1, 2026 at a weighted average price of $60.5997 per share. Following this purchase, he directly owns 87,471 shares. The filing notes the shares were bought in multiple trades at prices ranging from $60.59 to $60.60 per share.

Insider Trade Summary

Net Buyer: 3,310 shares

Net Buy 1 txn

Insider SACCARO JAMES

Role Chief Financial Officer

Bought 3,310 shs ($201K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $0.01 per share	3,310	$60.5997	$201K

Holdings After Transaction: Common Stock, par value $0.01 per share — 87,471 shares (Direct)

Footnotes (1)

1. F1. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Key Figures

Shares purchased: 3,310 shares Purchase price: $60.5997 per share Post-transaction holdings: 87,471 shares +2 more

5 metrics

Shares purchased 3,310 shares Open-market purchase on May 1, 2026

Purchase price $60.5997 per share Weighted average price for purchased shares

Post-transaction holdings 87,471 shares Direct ownership after the May 1, 2026 trade

Price range of trades $60.59–$60.60 per share Footnote-disclosed range for individual purchase executions

Net buy shares 3,310 shares Transaction summary net buy across all reported trades

Key Terms

open-market purchase, weighted average price, Common Stock, par value $0.01 per share, transaction code P

4 terms

open-market purchase financial

"transaction_action is described as an open-market purchase"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported represents the weighted average price of shares purchased."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock, par value $0.01 per share financial

"security_title lists Common Stock, par value $0.01 per share"

transaction code P regulatory

"transaction_code P indicates a purchase in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GEHC CFO James Saccaro report?

GE HealthCare Technologies CFO James Saccaro reported an open-market purchase of 3,310 shares of Common Stock. The transaction occurred on May 1, 2026, and reflects a direct ownership increase rather than a sale or derivative exercise.

At what price did GEHC CFO James Saccaro buy the shares?

James Saccaro bought the 3,310 GE HealthCare Technologies shares at a weighted average price of $60.5997 per share. A filing footnote explains the shares were purchased in multiple trades between $60.59 and $60.60 per share.

How many GEHC shares does James Saccaro own after this transaction?

After the reported purchase, James Saccaro directly owns 87,471 shares of GE HealthCare Technologies Common Stock. This post-transaction holding amount is disclosed in the Form 4 as the total shares following the May 1, 2026 transaction.

Was the GEHC CFO transaction a buy or a sell?

The GE HealthCare Technologies CFO transaction was a buy. The Form 4 lists transaction code P and describes it as an open-market purchase, with 3,310 shares acquired and no shares sold in this reported activity.

Did GEHC CFO James Saccaro use derivatives in this Form 4 transaction?

No, the reported transaction involved only non-derivative Common Stock. The filing classifies the activity as a non-derivative open-market purchase, and the derivative position summary in the data shows no derivative transactions or remaining derivative positions tied to this event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 11:38 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SACCARO JAMES

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/01/2026		P		3,310	A	$60.5997(1)	87,471	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported represents the weighted average price of shares purchased. These shares were purchased in multiple transactions at prices ranging from $60.59 to $60.60, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)